IGF-1 LR3 1 mg is a modified Insulin-like Growth Factor-1 analogue under investigation in cell-proliferation, muscle-biology, and IGF-axis research. The LR3 modification extends the working half-life in research models.
Research Profile
- Modified IGF-1 analogue (Long R3)
- Studied in IGF-axis, cell-proliferation, and tissue-biology research
- Long history of academic research in growth and development
- QC verified by HPLC and mass spectrometry
Specifications
- Compound: IGF-1 LR3
- Dosage: 1 mg per vial
- Purity: ≥ 98% (HPLC)
- Form: Lyophilized powder
- Storage: 2–8 °C (lyophilized); –20 °C (reconstituted)
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.
